Trial Profile
An open label,single dose,randomised study to evaluate pharmacokinetics,safety and tolerability of Sulcardine sulfate in healthy chinese subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Sulcardine (Primary)
- Indications Arrhythmias
- Focus Adverse reactions; Pharmacokinetics
- 06 Jun 2017 New trial record